Archive
DERMAPHARM HOLDING SE
Corporate News
April 13, 2021 | Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
Corporate news
to the archive
Dermapharm forecasts exceptionally strong growth for 2021 and confirms preliminary figures
Revenue and earnings up due to organic growth and successful acquisitions
Vaccine production to commence in May 2021 ...
February 12, 2021 | Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021
Corporate news
to the archive
Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021
Grünwald, February 12, 2021 - Dermapharm Holding ...
November 16, 2020 | Dermapharm Holding SE continues on its growth course in third quarter of 2020
Corporate news
to the archive
Dermapharm Holding SE continues on its growth course in third quarter of 2020
Group revenue rose by 11.5% to EUR 577.2 million
Adjusted Group EBITDA increased by 4.4% to EUR 139.0 million; corresponding ...
Ad hoc News
12 February 2021 | Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021
Ad hoc news
to the archive
Dermapharm Holding SE expects the cooperation with BioNTech SE in vaccine production to make a high double-digit million € contribution to sales in 2021
Grünwald, February 12, 2021 - Dermapharm Holding SE (WKN: ...
10 September 2020 | Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE
Ad hoc news
to the archive
Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE
Grünwald, September 10, 2020 – Dermapharm Holding SE (WKN: A2GS5D, ISIN: DE000A2GS5D8) and BioNTech SE, Mainz, Germany, ...
February 8, 2018 | Dermapharm Holding SE sets offer price at EUR 28.00 per share
Ad hoc news
to the archive
Dermapharm Holding SE sets offer price at EUR 28.00 per share
Grünwald, February 8, 2018 - Today, Dermapharm Holding SE (together with its consolidated subsidiaries, "Dermapharm", ISIN: ...